- Home
- BBW vs RLAY Comparison
BBW vs RLAY Comparison
Compare BBW & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBW
- RLAY
- Stock Information
- Founded
- BBW 1997
- RLAY 2015
- Country
- BBW United States
- RLAY United States
- Employees
- BBW N/A
- RLAY N/A
- Industry
- BBW Recreational Games/Products/Toys
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBW Consumer Discretionary
- RLAY Health Care
- Exchange
- BBW Nasdaq
- RLAY Nasdaq
- Market Cap
- BBW 672.6M
- RLAY 610.3M
- IPO Year
- BBW 2004
- RLAY 2020
- Fundamental
- Price
- BBW $56.57
- RLAY $3.69
- Analyst Decision
- BBW Strong Buy
- RLAY Strong Buy
- Analyst Count
- BBW 5
- RLAY 12
- Target Price
- BBW $57.60
- RLAY $18.45
- AVG Volume (30 Days)
- BBW 231.3K
- RLAY 2.0M
- Earning Date
- BBW 08-28-2025
- RLAY 08-07-2025
- Dividend Yield
- BBW 1.55%
- RLAY N/A
- EPS Growth
- BBW 19.03
- RLAY N/A
- EPS
- BBW 4.15
- RLAY N/A
- Revenue
- BBW $510,069,000.00
- RLAY $8,355,000.00
- Revenue This Year
- BBW $6.10
- RLAY $31.55
- Revenue Next Year
- BBW $3.90
- RLAY N/A
- P/E Ratio
- BBW $13.63
- RLAY N/A
- Revenue Growth
- BBW 6.09
- RLAY N/A
- 52 Week Low
- BBW $27.44
- RLAY $1.78
- 52 Week High
- BBW $59.78
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- BBW 59.90
- RLAY 58.31
- Support Level
- BBW $52.54
- RLAY $3.31
- Resistance Level
- BBW $59.78
- RLAY $3.65
- Average True Range (ATR)
- BBW 2.44
- RLAY 0.18
- MACD
- BBW 0.26
- RLAY 0.01
- Stochastic Oscillator
- BBW 69.49
- RLAY 93.01
About BBW Build-A-Bear Workshop Inc.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).